Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse

Rev Neurol (Paris). 2021 Apr;177(4):436-439. doi: 10.1016/j.neurol.2020.08.004. Epub 2020 Nov 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Central Nervous System
  • Central Nervous System Neoplasms* / diagnosis
  • Cerebrospinal Fluid
  • Humans
  • Interleukin-10
  • Lymphoma, Non-Hodgkin*
  • Neoplasm Recurrence, Local / diagnosis

Substances

  • Biomarkers
  • Interleukin-10